Alterity Therapeutics Limited
ATHE · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $0 | -$7,173 | -$12,616 | $0 |
| Dep. & Amort. | $0 | $0 | $74 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $1,121 | $570 | $0 |
| Change in WC | $3,440 | -$2,009 | $3,138 | $1,622 |
| Other Non-Cash | -$5,796 | -$298 | $724 | -$6,117 |
| Operating Cash Flow | -$2,355 | -$8,360 | -$8,111 | -$4,495 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$7,500 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | -$1 | $1 |
| Investing Cash Flow | -$7,500 | $0 | -$1 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$127 | -$68 | -$10 | -$55 |
| Stock Issued | $27,175 | $399 | $95 | $1,126 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,805 | $39 | $8,082 | -$101 |
| Financing Cash Flow | $25,242 | $369 | $8,166 | $970 |
| Forex Effect | -$185 | -$61 | $263 | -$495 |
| Net Chg. in Cash | $15,202 | -$4,746 | $318 | -$4,389 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $17,957 | $9,283 | $12,320 | $16,709 |
| End Cash | $33,159 | $4,537 | $12,639 | $12,320 |
| Free Cash Flow | -$2,355 | -$8,360 | -$8,111 | -$4,864 |